Project Number 7U01AG047222-05 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Allopregnanolone a Regenerative Therapy for Alzheimers: FDA-Required Toxicology Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator BRINTON, ROBERTA EILEEN Principal Investigator First Name ROBERTA Principal Investigator Last Name BRINTON Awardee Organization UNIVERSITY OF ARIZONA Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-590: Change of Grantee Organization (Type 7 Parent Clinical Trial Optional) FY Overall Cost $239,276 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA
